Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Polyrizon Ltd. ( (PLRZ) ) has issued an announcement.
Polyrizon Ltd. released its interim condensed financial statements for the period ending June 30, 2025, showing a significant increase in cash and cash equivalents from $2,554,000 in December 2024 to $15,828,000 in June 2025. Despite an operating loss of $2,485,000, the company reported a reduced net loss of $177,000, compared to $588,000 in the same period last year, due to financial income gains. This financial update may indicate improved financial health and potential for future growth.
More about Polyrizon Ltd.
Polyrizon Ltd. operates in the biotechnology industry, focusing on developing innovative solutions for biological threats and allergens. The company is headquartered in Raanana, Israel.
Average Trading Volume: 6,217,392
Technical Sentiment Signal: Strong Sell
Current Market Cap: $7.07M
For an in-depth examination of PLRZ stock, go to TipRanks’ Overview page.